Lokman Hekim University
Ankara, 06510, Turkey (Türkiye)
Location status: Recruiting
Location contact
Başak Çağla Arslan, Master's Degree
CONTACT
NCT Number: NCT06402942
This research aims to improve the quality of life, occupational performance, occupational satisfaction and emotional health of young people with Duchenne muscular dystrophy compared to the classical occupational therapy program. The findings are planned to shed light on the development of new and effective strategies in the rehabilitation of adolescents with Duchenne muscular dystrophy.
Interested in participating?
Request Info13 year–18 year
Male
Interventional
Not applicable
Ankara, 06510, Turkey (Türkiye)
Location status: Recruiting
Başak Çağla Arslan, Master's Degree
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Gamified occupational therapy program for the experimental group and classical occupational therapy program for the control group, which will be applied to both groups for eight weeks
Gamified occupational therapy program for the experimental group and classical occupational therapy program for the control group, which will be applied to both groups for eight weeks
Time frame: At the start of the evaluations
Time frame: before and after the eight-week intervention programs
Time frame: before and after the eight-week intervention programs
This scale was developed to assess the level of ambulation in neuromuscular diseases and consists of 10 stages. In this scale, the ambulation level of the person decreases from the first stage to the tenth stage.
Time frame: before and after the eight-week intervention programs
This scale was developed to assess the functional levels of the upper extremity in neuromuscular diseases and consists of 6 stages. In this scale, progression from the first stage to the sixth stage indicates a decrease in the functionality of the upper extremity.
Time frame: before and after the eight-week intervention programs
Time frame: before and after the eight-week intervention programs
Time frame: before and after the eight-week intervention programs
Consisting of 27 items and using a 3-point Likert-type scale, this scale assesses the depression levels of children between the ages of 6-17. The total score of the scale, which measures the emotional state in the last 2 weeks, is 54 and the severity of depression increases as the total score increases. The cut-off value of the scale was determined as 19 points.
Time frame: before and after the eight-week intervention programs
This scale consists of 18 items and 3 subsections: general fatigue (6 items), fatigue during sleep/rest (6 items) and cognitive fatigue (6 items). Separate scores can be calculated for each subsection and the total score is obtained by summing the scores obtained from these sections. High scores indicate low fatigue.
Time frame: before and after the eight-week intervention programs
This scale uses a 10-centimeter line. The left beginning of the line represents "no pain" (0 points) and the end of the line represents "excruciating pain" (10 points).
Contact information is provided by the study sponsor or research team.
Başak Çağla Arslan
Other Gov
Acronym: DMD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06817382
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy
Little Rock, Arkansas, United States
View Trial DetailsNCT05933057
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy
Leuven, Belgium
View Trial DetailsNCT07287189
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DMD
Los Angeles, California, United States
View Trial DetailsNCT06564974
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy
Phoenix, Arizona, United States
View Trial Details